Astellas Pharma Inc. 13D and 13G filings for Taysha Gene Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-18 5:16 pm Purchase |
2023-08-16 | 13D | Taysha Gene Therapies, Inc. TSHA |
Astellas Pharma Inc. | 7,266,342 3.890% |
7,266,342 (New Position) |
Filing |